Zyprexa Failure-To-Warn Suit Survives In MDL
A federal judge has refused to throw out a woman's claims that Eli Lilly & Co.'s anti-psychotic Zyprexa caused her to develop diabetes, finding that a material issue of fact remains...To view the full article, register now.
Already a subscriber? Click here to view full article